rs78132896

This is a upstream gene variant variant in the EPHA7 gene.

GWAS Catalog Trait Associations (1)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

response to anticoagulant

Allele C
OR 8.27
p 2.0e-11
N 215
Small GWAS
African American or Afro-Caribbean

Research that mentions this SNP (1)

Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent
AssociationN=403Tanima De et al.(2018)· JAMA

This genome-wide association study identified four SNPs on chromosome 6 (rs78132896, rs16871327, rs115112393, rs114504854) in the EPHA7 gene that are associated with warfarin-associated major bleeding in African Americans. Meta-analysis of discovery (31 cases, 184 controls) and replication (40 cases, 148 controls) cohorts showed genome-wide significant association (OR 8.27, 95% CI 4.18–16.38, P = 2.05 × 10⁻¹¹). These SNPs are found only in African descent populations.

Traits studied:Major bleedingWarfarin-associated bleeding

About EPHA7

This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Increased expression of this gene is associated with multiple forms of carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]

View all EPHA7 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…